Schistosomiasis, also known as bilharzia, is a chronic liver and intestinal parasitic disease caused by trematode worms of the genus Schistosoma. Among the five major species of human schistosomes, Schistosoma mansoni is the most prevalent, being endemic in 54 countries. Praziquantel is the only available drug against all forms of schistosomiasis. The development of praziquantel resistance is a great concern and new drugs are urgently
In previous work, bioassay-guided fractionation of the methanol extract of the aerial parts of M. balsamina led to the isolation of several cucurbitane-type triterpenoids. Our results indicate that karavilagenin C and balsaminol F possesses in vitro schistosomicidal activity against S. Mansoni adult worms. Then, cucurbitane derivatives might be used, in the future, as lead compounds for the development of new schistosomicidal agents. For the in vitro test with S. mansoni, compounds 1-10 were dissolved in 10% DMSO and used in concentrations ranging between 5 to 100 M, which were added to the medium containing one adult pair. Parasites were evaluated for their general condition: motor activity, alterations in the tegument, mortality rate, and egg production and development.
A remarkable schistosomicidal activity was observed for karavilagenin C and balsaminol F at 50 and 100 µM, which caused the death of all S. mansoni adult worms after 24 h of incubation. Both compounds, at 10-50 µM, induced significant reductions in the motor activity of the worms (data no shown) and significantly decreased the egg production (Fig. 3) . Furthermore, they were able (at 10-100 µM) to separate the adult worm pairs into male and female after 24 h (data no shown). 
